| ASSET | QUARTER | % RETURN |
|---|---|---|
Inventrust Properties (IVT) | Q1 2020 | 80% |
Moderna (MRNA) | Q1 2020 | 53.04% |
Twist Bioscience (TWST) | Q1 2020 | 44.11% |
Virtu Financial (VIRT) | Q1 2020 | 31.57% |
Cogent Communications (CCOI) | Q1 2020 | 25.54% |
Ringcentral (RNG) | Q1 2020 | 24.65% |
Zai Lab (ZLAB) | Q1 2020 | 23.31% |
CLARIVATE (CLVT) | Q1 2020 | 23.07% |
Enphase Energy (ENPH) | Q1 2020 | 22.45% |
Qiagen (QGEN) | Q1 2020 | 21.32% |
Bilibili (BILI) | Q1 2020 | 20.29% |
iRhythm Technologies (IRTC) | Q1 2020 | 18.45% |
Palomar (PLMR) | Q1 2020 | 14.94% |
Masimo (MASI) | Q1 2020 | 12.03% |
Cytokinetics (CYTK) | Q1 2020 | 10.81% |
TAL Education (TAL) | Q1 2020 | 10.06% |
GDS (GDS) | Q1 2020 | 9.87% |
Amedisys (AMED) | Q1 2020 | 9.36% |
Vipshop (VIPS) | Q1 2020 | 9.18% |
Tootsie Roll Industries (TR) | Q1 2020 | 8.65% |
PLDT Inc ADR (PHI) | Q1 2020 | 8.38% |
WM Technology (MAPSW) | Q1 2020 | 8.33% |
ICU Medical (ICUI) | Q1 2020 | 7.78% |
FTI Consulting (FCN) | Q1 2020 | 7.57% |
Freshpet (FRPT) | Q1 2020 | 7.49% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
